Business Segment and Geographical Information

3 Months Ended

Apr. 02, 2022

Segment Reporting [Abstract]

Business Segment and Geographical Information [Text Block]

Note 4.    Business Segment and Geographical Information

Business Segment Information

	Three months ended
	April 2,		April 3,
(In millions)	2022		2021
Revenues
Life Sciences Solutions	$	4,231	$	4,203
Analytical Instruments	1,518		1,387
Specialty Diagnostics	1,482		1,615
Laboratory Products and Biopharma Services	5,442		3,597
Eliminations	(855)		(896)
Consolidated revenues	11,818		9,906
Segment Income
Life Sciences Solutions	2,176		2,279
Analytical Instruments	301		272
Specialty Diagnostics	353		428
Laboratory Products and Biopharma Services	620		531
Subtotal reportable segments	3,450		3,510
Cost of revenues adjustments	(11)		(8)
Selling, general and administrative expenses adjustments	(7)		(16)
Restructuring and other costs	(2)		(14)
Amortization of acquisition-related intangible assets	(609)		(423)
Consolidated operating income	2,821		3,049
Interest income	18		12
Interest expense	(136)		(125)
Other income/(expense)	(163)		(183)
Income before income taxes	$	2,540	$	2,753

Cost of revenues adjustments included in the above table consist of charges for the sale of inventories revalued at the date of acquisition. Selling, general and administrative expenses adjustments included in the above table consist of third-party transaction/integration costs related to recent acquisitions, and charges/credits for changes in estimates of contingent acquisition consideration.

Geographical Information

Revenues by country based on customer location are as follows:

	Three months ended
	April 2,		April 3,
(In millions)	2022		2021
Revenues
United States	$	6,097	$	4,892
China	910		775
Other	4,811		4,239
Consolidated revenues	$	11,818	$	9,906